Tonghuashun (300033) Financial Research Center, May 14abu7500c3ct, some investors asked Xingqi Eye Medicine (300573)(300573), Hello Secretary Dong! May I ask if your company's atropine (American-European product) is currently on the market, and there are 70 million young myopia patients across the country. Can the company's current production capacity keep up? Whether atropine has a chance to get medical insurance this year. Thank you!

The company replied, Dear investor, the company's production capacity can currently meet market demand. Regarding whether atropine will enter medical insurance, the company will make appropriate decisions based on market conditions. Thank you for your attention.